Stocks-RIGL-Rigel Pharmaceuticals Inc

RIGL Rigel Pharmaceuticals Inc

12.95 -0.02 (-0.15%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-RIGL-Rigel Pharmaceuticals Inc
RIGL Rigel Pharmaceuticals Inc
Trade

Overview

Prev Close 12.95
Day's Range 12.64 - 13.00
52 Week Range 6.90 - 17.00
Average Volume (3M) 158.56K
1-Year Return 20.38%
Beta1.5184
Market Cap 228.21M
P/E Ratio-15.94
Revenue130.3M
EPS-0.8136
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Raul R. Rodriguez, MBA
Employees
147

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Rigel Pharmaceuticals Inc's revenues decreased by 2.79% and amounted to 116.88M. Net income increased by 57.16% to -25.09M. Net assets decreased by 110.37% to -28.64M and EPS increased from -0.34 to -0.14.
RIGL's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-20M-10M010M20M30M40M
Gross Margin
92.41%
Net Profit Margin
-44.48%
Operating Margin
-6.92%
Return On Investment
-96.99%
09/23
12/23
03/24
06/24
Total Revenue
28.13M
35.79M
29.53M
36.84M
Gross Profit
26.87M
32M
27.51M
34.03M
Operating Income
-4.47M
1.97M
-6.97M
447K
Net Income
-5.69M
737K
-8.25M
-1.03M